Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
World Neurosurgery|February 11, 2023
Prognostic Factors and Treatment Impact on Overall Survival in Adult CraniopharyngiomaMatthew Awad, John T Butterfield, Sanjay Dhawan, et al.International Forum of Allergy & Rhinology|February 5, 2020
Nasal vestibular body treatment for recalcitrant nasal obstructionNour Ibrahim, Matthew A Tyler, Nicole A Borchard, et al.Human Gene Therapy|May 24, 2006
CD46 represents a target for adenoviral gene therapy of malignant gliomaIlya V Ulasov, Matthew A Tyler, Sophy Zheng, et al.Human Gene Therapy|March 3, 2007
Novel recombinant adenoviral vector that targets the interleukin-13 receptor alpha2 chain permits effective gene transfer to malignant gliomaIlya V Ulasov, Matthew A Tyler, Yu Han, et al.Stem Cell Reviews and Reports|March 19, 2010
Cancer stem cells: the final frontier for glioma virotherapyMahua Dey, Ilya V Ulasov, Matthew A Tyler, et al.Current Gene Therapy|October 29, 2009
Stem cells as delivery vehicles for oncolytic adenoviral virotherapyJustin Kranzler, Matthew A Tyler, Adam M Sonabend, et al.The Journal of Gene Medicine|March 14, 2007
Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant gliomaSophy Zheng, Ilya V Ulasov, Yu Han, et al.Journal of Neurological Surgery. Part B, Skull Base|July 14, 2022
Estimating Risk of Pituitary Apoplexy after Resection of Giant Pituitary AdenomasJohn T Butterfield, Takako Araki, Daniel Guillaume, et al.Journal of Medical Virology|July 24, 2008
Evaluation of E1A double mutant oncolytic adenovectors in anti-glioma gene therapyIlya V Ulasov, Matthew A Tyler, Angel A Rivera, et al.Stem Cells (Dayton, Ohio)|January 15, 2008
Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial gliomaAdam M Sonabend, Ilya V Ulasov, Matthew A Tyler, et al.Pageof 4